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http://www.biomedcentral.com/1471-2474/14/262RESEARCH ARTICLE Open AccessSmoking and primary total hip or knee
replacement due to osteoarthritis in 54,288
elderly men and women
George Mnatzaganian1*, Philip Ryan2,3, Christopher M Reid4, David C Davidson5 and Janet E Hiller1,2Abstract
Background: The reported association of smoking with risk of undergoing a total joint replacement (TJR) due to
osteoarthritis (OA) is not consistent. We evaluated the independent association between smoking and primary TJR
in a large cohort.
Methods: The electronic records of 54,288 men and women, who were initially recruited for the Second Australian
National Blood Pressure study, were linked to the Australian Orthopaedic Association National Joint Replacement
Registry to detect total hip replacement (THR) or total knee replacement (TKR) due to osteoarthritis. Competing risk
regressions that accounted for the competing risk of death estimated the subhazard ratios for TJR. One-way and
probabilistic sensitivity analyses were undertaken to represent uncertainty in the classification of smoking exposure
and socioeconomic disadvantage scores.
Results: An independent inverse association was found between smoking and risk of THR and TKR observed in
both men and women. Compared to non-smokers, male and female smokers were respectively 40% and 30% less
likely to undergo a TJR. This significant association persisted after controlling for age, co-morbidities, body mass
index (BMI), physical exercise, and socioeconomic disadvantage. The overweight and obese were significantly more
likely to undergo TJR compared to those with normal weight. A dose–response relationship between BMI and TJR
was observed (P < 0.001). Socioeconomic status was not independently associated with risk of either THR or TKR.
Conclusion: The strengths of the inverse association between smoking and TJR, the temporal relationship of the
association, together with the consistency in the findings warrant further investigation about the role of smoking in
the pathogenesis of osteoarthritis causing TJR.
Keywords: Total joint replacement, Smoking, Socioeconomic status, Exposure misclassification, Sensitivity analysisBackground
The incidence of total hip replacement (THR) and total
knee replacement (TKR) has steadily increased over the
past two decades and continues to rise as global popula-
tions grow [1-3]. In both men and women the procedure
rates increase with age as patients reach their late 70s,
after which the rates decline [3]. Lower limb total joint re-
placement (TJR) has become an effective and successful
treatment for osteoarthritis (OA) of the hip and knee
which is the most common musculoskeletal disorder to* Correspondence: George.Mnatzaganian@acu.edu.au
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article, unless otherwise stated.cause pain and disability in elderly populations and is the
leading cause of this procedure [4]. Besides old age, some
of the independent risk factors for this disorder include fe-
male gender [1,3], obesity [5], physical activity [6], and
never-smoking [7-9]. However, the reported association of
smoking with increased or decreased risk of osteoarthritis
or total joint replacement has not been consistent [7-12].
Smoking has variously shown a negative association with
OA [7,8] or TJR [9], a positive association with OA [10] or
TJR [11], and no significant association with OA [12]. It
has been suggested that the inverse association between
smoking and TJR due to OA may be explained by various
confounding factors such as body weight. Obesity is a
major risk factor for OA [5,7] or TJR [9] and because bodyCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Mnatzaganian et al. BMC Musculoskeletal Disorders 2013, 14:262 Page 2 of 11
http://www.biomedcentral.com/1471-2474/14/262mass index often decreases with increasing duration of
smoking [13,14], smokers who, in general, may be leaner
than the non-smokers may be less likely to develop OA.
Other proposed confounders of the inverse association are
physical activity [6,15] and socioeconomic status (SES)
[16]. The association of socioeconomic disadvantage with
lower rates of joint replacements has been reported.
People coming from such disadvantaged backgrounds
often smoke more and are more likely to suffer from
tobacco-related co-morbidities [17]. Similarly, compared
with more affluent population groups, such patients may
wait longer for surgery and may also have less access to
TJR procedures [16,18]. The inverse association is further
explained by probable misclassification bias of the smok-
ing status, confounding by unknown factors, and by selec-
tion biases of the controls as suggested by Hui et al. [19].
In a previous analysis, we found an independent inverse
dose–response relationship between duration of smoking
and risk of undergoing a total joint replacement in 11,388
elderly men coming from the population-based cohort -
the Health In Men Study (HIMS) [9]. This inverse associ-
ation persisted after adjusting for confounding factors
including age, co-morbidities, body weight, physical exer-
cise, and various socioeconomic and demographic factors
and also after accounting for the competing risk of death.
One limitation of our previous study was that the data in-
cluded only men and therefore the results were not
generalizable to women. Furthermore, that study did not
account for possible misclassification biases. To examine
this association in another independent sample and evalu-
ate if it existed also in women, we used a much larger sam-
ple of 54,288 elderly men and women belonging to the
Second Australian National Blood Pressure Study (ANBP2)
[20]. We hypothesized that if a possible association were to
be supported between smoking and lower risk of either
THR or TKR, such an association needed to be observed
again in men but also in women in the independent
ANBP2 sample. In this analysis, we further ran one-way
and probabilistic sensitivity analyses (PSA) [21,22] to ac-
count for potential biases related to uncertainties in the
classification of 1) the smoking status, and 2) the socioeco-
nomic disadvantage scores.Methods
Ethics statement
Ethical approval for the study was obtained from the
Human Research Ethics Committees of 1) The University
of Adelaide, 2) ANBP2 study, and 3) the Australian Insti-
tute of Health and Welfare (AIHW) National Death Index
prior to commencement of study. All analyses used de-
identified data. The need for informed consent was waived
by the ethical committees due to de-identified data being
used.Study population
The study population is drawn from the Second
Australian National Blood Pressure study that was
conducted at 1594 family medical practices throughout
Australia [20]. The objective of the original study was to
assess in hypertensive subjects 65–84 years of age,
whether there was any difference in cardiovascular events
over a 5-year treatment period between antihypertensive
treatment with an ACE inhibitor-based regimen and treat-
ment with a diuretic-based regimen. The general practi-
tioners, who were approached and were willing to
participate in the study, provided a list of potential eligible
hypertensive subjects 65 years of age or older. During
1995–1998, a total of 54,288 subjects were screened for
eligibility to participate in ANBP2.Study independent variables
At baseline screening of the original ANBP2 study, a
questionnaire was completed that included socio-
demographic data, presence of co-morbidities and life-
style factors including current tobacco use, daily alcohol
consumption, and engagement in physical activity.
Height and weight and other measures of obesity (i.e.,
arm, waist and hip circumferences) were measured by a
research nurse and body mass index (BMI) was calcu-
lated. The systolic and diastolic blood pressures were
also measured. Both smokers and non-smokers were de-
fined at baseline according to smoking status (yes/no)
and all participants were followed for the study outcome
from the same index date. General practitioners and re-
search nurses also provided information on study partic-
ipants’ co-morbidities. Participant-reported physical
exercise variable was defined as engaging in weekly exer-
cise that lasted more than 30 minutes. The socioeco-
nomic status (SES) was measured by the Socioeconomic
Index For Areas (SEIFA) which is based on data from
the 1996 census for residential postcodes [23]. SEIFA is
a composite index that ranks geographic areas across
Australia in terms of their relative socio-economic ad-
vantage and disadvantage based on census data, where
lower scores indicate more disadvantaged areas and
higher scores indicate more advantaged areas. The score,
which has been validated by the Australian Bureau of
Statistics [23], is constructed using a number of different
variables that indicate both advantage (i.e. high income,
having a degree qualification) and disadvantage (i.e. un-
employment status, low income, not enough bedrooms).
For example, an area could have a low score if there are,
among other things, many households with low incomes,
or many people in unskilled occupations. This index is
frequently used in Australian epidemiological studies
where individual measures of socioeconomic status are
not available.
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The electronic records of the initially screened 54,288
men and women were linked to the Australian Ortho-
paedic Association National Joint Replacement Registry
(AOA NJRR) [24] to detect primary total hip or knee re-
placements due to osteoarthritis from 1 September 1999
till 31 December 2010. In this study we considered TJR
as a surrogate indicator of severe OA. Follow-up for TJR
did not commence at baseline screening (1995–1998)
since at baseline joint replacement procedures were still
not registered in a national registry. Mean time from
baseline screening to national complete capture of lower
limb joint replacements by the AOA NJRR was 2.3 (SD
0.6) years [median of 2.2 years].
All-cause mortality was ascertained through linkage
with the Australian Institute of Health and Welfare
(AIHW) National Death Index [25].
Statistical analysis
We excluded from the analysis 1) participants who died
between baseline screening and start of follow-up for
TJR, 2) participants who reported having a TJR before
start of follow-up, and 3) those who had missing base-
line information. The remaining eligible attendants were54,288
Subjects screened for eligibili
(1995-1998)
44,614 (82.2%)
Followed for first TJR
Start of follow-up: 1 September 





Figure 1 Flow chart of screening and follow-up for first total joint repfollowed until they experienced their first hip or knee re-
placement procedure due to osteoarthritis or died or
were right censored at the end of follow-up (December,
2010) (Figure 1). Only the first lower limb replacement
procedure was considered.
Total joint replacement was separately modelled for
males and females on age, Charlson Co-morbidity Index,
body mass index, socioeconomic disadvantage, smoking,
physical exercise, alcohol intake, screening systolic and
diastolic blood pressures and presence of a mental co-
morbidity at baseline using competing risk regressions
(CRR) as defined by Fine and Gray [26]. The analyses
assessed the effect of predictors on the hazard of the
subdistribution for TJR (the "subhazard") while account-
ing for the competing risk of death since the study
population was elderly and death represented a compet-
ing risk that reduced the number of individuals at risk of
the event of interest, TJR [26-28]. The regression model
for competing risks of Fine and Gray estimates the ratios
of the hazards of the subdistributions, a natural exten-
sion of Cox modelling for hazards in the non-competing
risks situation. The hazard of the subdistribution [for
TJR] can be interpreted as the probability of observing
the event of interest in the next time interval whilety 
2,141 (3.9%)
Died from baseline and start 
of follow-up
389 (0.7%)
Had had TJR before start of
              follow-up  
7,144 (13.0%)
With missing information at 





lacement due to osteoarthritis: the ANBP2 study.
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or the competing event did happen [26].
The Charlson Co-morbidity Index [29] used to adjust
for co-morbidity was based on all co-morbidities reported
by the general practitioner, the research nurse and the
study participants. The study outcomes were also mod-
elled using the individual co-morbid conditions that form
the Charlson index. The method used to build the score
was similar to that reported by Chaudhry et al. [30]. The
original Charlson weights were used to form the co-
morbidity index [31]. We further separately modelled
THR and TKR using similar methods as explained above.
The proportional hazard assumptions were tested in each
of the models using Schoenfeld residuals.
One-way and probabilistic sensitivity analyses
Misclassification of smoking
At baseline screening, the study participants were asked
to state their current smoking status, a yes or no question.
Misclassification of this variable could occur if, for ex-
ample, a subject declines to reveal his/her smoking status,
thus introducing uncertainty in the measure of sensitivity
of this exposure variable. Sensitivity is defined as the prob-
ability of a true smoker being classified as a smoker. An-
other uncertainty relates to the specificity of the smoking
variable. Specificity is defined as the probability of a non-
smoker being classified as a non-smoker. Here, uncertainty
may theoretically occur due to a coding error, or when sub-
jects falsely claim to smoke. The latter is less likely because,
generally, non-smokers do not usually claim to smoke,
therefore the main uncertainty in the smoking exposure re-
lates to the sensitivity measure.
Under the assumption that non-smokers are less likely
to claim smoking, we conducted one-way sensitivity ana-
lyses to calculate the expected risk ratios of having a TJR
associated with smoking under various sensitivity mea-
sures (i.e., 0.99, 0.95, 0.90, 0.80, 0.75, 0.70, 0.60 and
0.50), while holding the specificity constant. For ex-
ample, a sensitivity of 0.90 would indicate a misclassifi-
cation of 10%, i.e., 10% of the smokers declined to reveal
their smoking status and were misclassified as non-
smokers while in fact they did smoke.
Since uncertainty can theoretically affect the sensitivity
as well as the specificity, as suggested by Jurek et al. [21]
and Orsini et al. [22], the possible scenarios of different
sensitivity and specificity values (for example 1.0 or 0.9
or 0.8 or 0.75) were assessed simultaneously using prob-
abilistic sensitivity analysis (PSA) through Monte Carlo
simulations with 20,000 replications. A misclassification-
bias-adjusted relative risk was estimated under a variety
of possible fixed sensitivities and specificities of smoking
classification among those with and without TJR.
The one-way and probabilistic sensitivity analyses were
undertaken under the assumption that misclassificationof smoking status was not associated with having a total
joint replacement.
Misclassification of socioeconomic status (SES)
As stated above, the SES was measured by the Socioeco-
nomic Index For Areas (SEIFA) disadvantage score that
was based on the residential postcode. Misclassification
of SEIFA may occur due to different reasons such as
coding error or wrong residential address. To account
for this possible uncertainly, as explained above, we
conducted a PSA.
All analyses were performed using Stata statistical pro-
gram (version 11, Stata-Corp.).
Results
Exclusions
At baseline (1995–98), a total of 54,288 hypertensive
men and women (mean age 72.9 (SD 5.1) years) were
screened for eligibility (Figure 1). Over 70% of the sub-
jects were screened during 1997–1998. For this current
analysis, of all screened the following were excluded
from the study: 1) 2,141 (3.9%) participants who died be-
tween baseline screening and start of follow-up for TJR,
2) 389 (0.7%) who reported having their TJR before start
of follow-up, and 3) 7,144 (13.0%) participants with
missing baseline information. The proportion of TJR
procedures in participants with missing information was
similar to those without missing information (8.4% ver-
sus 8.1% respectively, P = 0.4). Mean age of these two
groups was similar, and female proportions were not dif-
ferent (54.3% versus 55.5% respectively, P = 0.1).
Study population characteristics
Mean age at baseline was 72.8 (SD 5.0) years with a me-
dian age of 72 years ranging from 57 to 91 years. Of the
44,614 study participants, 3,535 (8%) reported smoking
at baseline screening. Compared to all others, the
current smokers were significantly younger, leaner, more
likely to be males, less likely to exercise, and more likely
to have higher Charlson co-morbidity indices (Table 1).
Similarly, smoking prevalence was higher among disad-
vantaged socioeconomic groups showing a gradient of
increasing proportions of smokers with decreasing
SEIFA scores observed in all participants and also when
stratified by obesity (defined as BMI > =30 kg/m2)
(Table 2). No significant differences were observed in
mean systolic or diastolic blood pressures between
current smokers and non-smokers.
Total joint replacement
All study participants were followed for a mean of 8.6
(SD 3.4) years till experiencing first primary THR or
TKR or death or censoring at the end of follow-up. Of
the 44,614 participants, 1,528 (3.4%) had a total hip
Table 1 Characteristics of study participants by smoking status defined at baseline screening
Characteristic Current smoking status P value
Yes smoking Not smoking
N = 3,535 (7.9%) N = 41,079 (92.1%)
Age, mean (SD) 71.4 (4.5) 73.0 (5.0) <0.001
Male gender, % 52.6 43.8 <0.001
BMI, % Kg/m2
Underweight <18.5 3.3 1.1
Normal weight 18.5 – 24.9 44.5 35.2
Overweight 25 – 29.9 38.1 44.7
Obese 30 – 34.9 11.9 15.4
Morbidly obese 35 or more 2.3 3.6 <0.001
SES, % 1st quintile – Lowest SES 27.3 19.7
2nd quintile 19.7 19.8
3rd quintile 19.6 20.1
4th quintile 17.9 20.2
5th quintile – Highest SES 15.6 20.2 <0.001
Charlson co-morbidity index, mean (SD) 0.4 (0.8) 0.3 (0.7) <0.001
Physical exercise > 30 minutes per week, % 49.7 55.8 <0.001
Daily alcoholic drink, % 15.4 7.1 <0.001
Screening systolic blood pressure, mean (SD) 143.0 (19.4) 143.5 (18.7) 0.135
Screening diastolic blood pressure, mean (SD) 79.5 (10.3) 79.2 (9.9) 0.140
Abbreviations: BMI (body mass index), SES (socioeconomic status based on the distribution of Socio-Economic Indexes for Areas (SEIFA) in the cohort).
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ment (Figure 1). Those who had either a THR or TKR
were significantly younger, healthier with lower Charlson
co-morbidity indices, heavier with higher body mass in-
dices, and were more likely to be female than those who
did not undergo this procedure. Compared with non-
smokers at baseline, current smokers were significantly
less likely to undergo a TJR procedure observed in allTable 2 Proportion of current smokers and TJR by BMI and so
1st quintile (Lowest SES) 2nd quintile
N = 9,046 N = 8,848
BMI < 30 (N = 36,305)
Current smokers, % 11.5 8.3!!
TJR, % 6.7 6.6
BMI > =30 (N = 8,309)
Current smokers, % 7.6 6.2
TJR, % 11.2 14.2!
All (N = 44,614)
Current smokers, % 10.7 7.9!!
TJR,% 7.7 8.1
Abbreviations: BMI (body mass index), SES (socioeconomic status based on the distr
joint replacement).
! 0.001 < P value < 0.05; !! P value < 0.001, comparison with Lowest SES (1st SEIFA quSES groups, age groups, and also seen in the obese and
non-obese (Table 3). The inverse association was more
prominently seen among the obese participants.
To assess the independent association of smoking with
risk of undergoing a TJR, we modelled TJR for men and
women separately while controlling for the factors listed
in Table 4. In a model that accounted for the competing
risk of death, smoking at baseline was independentlycioeconomic status
3rd quintile 4th quintile 5th quintile (Highest SES)







ibution of Socio-Economic Indices for Areas (SEIFA) in the cohort), TJR (total
intile).
Table 3 Proportions of TJR by BMI, SES, median age categories, and current smoking status
BMI SES categories Number of
participants
Age Age All ages
57–72 yrs 73 + yrs
BMI < 30 Low SES
Current smoker 1,208 5.5 4.8 5.2
Non smoker 10,567 8.2! 5.4 6.8!
Middle SES
Current smoker 999 4.9 4.1 4.6
Non smoker 11,074 8.8! 6.5 7.6!
High SES
Current smoker 829 5.8 3.2 4.8
Non smoker 11,628 9.1! 5.6 7.3!
All SES categories
Current smoker 3,036 5.4 4.1 4.9
Non smoker 33,269 8.7!! 5.8! 7.2!!
BMI > =30 Low SES
Current smoker 216 5.6 5.6 5.6
Non smoker 2,907 14.6! 10.1 12.8!!
Middle SES
Current smoker 160 8.8 3.5 6.9
Non smoker 2,634 17.1! 9.7 14.0!
High SES
Current smoker 123 9.2 8.0 8.9
Non smoker 2,269 14.3 9.5 12.3
All SES categories
Current smoker 499 7.5 5.1 6.8
Non smoker 7,810 15.4!! 9.8 13.0!!
ALL Current smoker 3,535 5.7 4.2 5.2
Non smoker 41,079 10.2!! 6.5! 8.3!!
Abbreviations: BMI (body mass index), SES (socioeconomic status based on the distribution of Socio-Economic Indices for Areas (SEIFA) in the cohort; Low SES 1st
tertile, Middle SES 2nd tertile, High SES 3rd tertile), TJR (total joint replacement).
! 0.001 < P value < 0.05; !! P value < 0.001, the non-smokers were compared with the smokers in all categories.
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men and women, although the association was stronger
in men. Compared to all others, men and women who
were smokers at baseline were respectively 40% and 30%
less likely to undergo a TJR (adjusted-sHRs: 0.60, CI 95%
0.48-0.75 in men, and 0.70, CI 95% 0.56-0.86 in women).
Risk of TJR was significantly higher among the over-
weight and obese showing a dose–response effect across
BMI categories (P < 0.001) in both genders. Adjusting
for BMI as a continuous variable and using different
measures of obesity (i.e. weight and height or arm, waist
and hip circumferences) produced similar associations
(results not shown). Engaging in weekly physical exercise
was a risk factor in men but not in women (Table 4).
To assess the association of smoking with different
joints, we further modelled THR and TKR separately
and found similar independent inverse associationsbetween smoking and TJR (Table 5), although the asso-
ciation was stronger in TKR. Similarly, the association of
BMI was stronger with TKR than with THR. Multivari-
able models for either THR or TKR were also conducted
separately for males and females with similar findings
(results not shown). The multivariable analyses were
similarly run using all 17 co-morbid conditions that
form the Charlson Index. The inverse association be-
tween smoking and TJR persisted also when individual
targeted co-morbid conditions were assessed. Since fit-
ting a statistical model to the data as a function of many
co-morbid conditions together with other study covari-
ates may result in model over-fitting [32], we preferred
to present the results with the single Charlson Index.
Interaction was assessed between smoking with either
BMI or physical exercise but no statistically significant
interactions were detected.
Table 4 Subdistribution hazard ratios of undergoing total joint replacement in males and females: multivariable
competing risk regressions! - accounting for the competing risk of death (N = 44,614)
Male Female
N = 19,864 N = 24,750
TJR: 1,405 (7.1%) TJR: 2,200 (8.9%)
Death prior to TJR: 46.8% Death prior to TJR: 34.2%
Covariates sHR (95% CI), P value sHR (95% CI), P value
Age, continuous 0.96 (0.95–0.97), <0.001 0.96 (0.95–0.97), <0.001
Charlson Index, continuous 0.75 (0.68–0.84), <0.001 0.73 (0.66–0.81), <0.001
BMI categories Kg/m2
Normal weight 18.5-24.9 (ref) 1.00 1.00
Underweight <18.5 0.41 (0.10–1.67), 0.214 0.31 (0.15–0.61), 0.001
Overweight 25–29.9 1.47 (1.22–1.76), <0.001 1.60 (1.39–1.83), <0.001
Obese 30–34.9 2.05 (1.67–2.52), <0.001 2.31 (2.00–2.67), <0.001
Morbidly obese ≥ 35 2.92 (2.15–3.97), <0.001 2.55 (2.09–3.09), <0.001
Current smoker, yes 0.60 (0.48–0.75), <0.001 0.70 (0.56–0.86), 0.001
Exercise > 30 minutes /per week, yes 1.13 (1.01–1.26), 0.035 1.00 (0.92–1.01), 0.966
SEIFA score, continuous 1.00 (1.00–1.00), 0.049 1.00 (0.99–1.00), 0.213
Screening SBP, continuous 0.99 (0.99–0.99), 0.010 0.99 (0.99–0.99), <0.001
!Also controlled for alcohol intake, and screening diastolic blood pressure.
Abbreviations: BMI (body mass index), SEIFA (Socio-Economic Indexes for Areas), SBP (systolic blood pressure), TJR (total joint replacement), sHR (subdistribution
hazard ratio).
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Table 6 shows the observed and expected risk ratios of
having a TJR associated with smoking using one-way
sensitivity analyses to account for uncertainty in the
probability of a true smoker being classified as a smokerTable 5 Subdistribution hazard ratios of undergoing total hip














!Also controlled for alcohol intake, physical exercise activity and screening diastolic
Abbreviations: BMI (body mass index), SEIFA (Socio-Economic Indexes for Areas), SBP
hazard ratio).(i.e., sensitivity). With specificity held constant, the ana-
lysis was separately run using different sensitivity mea-
sures of 0.99, 0.95, 0.90, 0.80, 0.75, 0.70, 0.60 and 0.50.
The inverse association between smoking and risk of
TJR remained statistically significant under uncertaintyor knee replacement: multivariable competing risk
44,614)
Total hip replacement Total knee replacement
sHR (95% CI), P value sHR (95% CI), P value
0.97 (0.96–0.98), <0.001 0.95 (0.94–0.96), <0.001
1.34 (1.21–1.49), <0.001 1.27 (1.16–1.39), <0.001
0.79 (0.71–0.88), <0.001 0.70 (0.63–0.77), 0.001
1.00 1.00
0.46 (0.22–0.97), 0.042 0.19 (0.06–0.58), 0.004
1.46 (1.25–1.71), <0.001 1.68 (1.44–1.95), <0.001
1.66 (1.38–1.99), <0.001 2.81 (2.39–3.30), <0.001
1.57 (1.17–2.09), 0.002 3.72 (3.03–4.57), <0.001
0.72 (0.58–0.90), 0.004 0.59 (0.48–0.73), 0.001
1.00 (0.99–1.00), 0.115 1.00 (0.99–1.00), 0.083
0.99 (0.99–0.99), 0.011 0.99 (0.99–0.99), <0.001
blood pressure.
(systolic blood pressure), TJR (total joint replacement), sHR (subdistribution
Table 6 Observed and expected risk ratios of having a total joint replacement associated with smoking: one-way
sensitivity analysis accounting for uncertainty in the classification of smoking exposure
Level of uncertainty! Sensitivity!! Risk ratio (95% CI) P value
Observed risk ratio - - 0.62 (0.54 – 0.72) <0.001
Expected risk ratios based on one-way sensitivity analyses!!! 1% .99 0.66 (0.58 – 0.75) <0.001
5% .95 0.76 (0.68 – 0.84) <0.001
10% .90 0.82 (0.75 – 0.90) <0.001
20% .80 0.89 (0.82 – 0.95) 0.001
25% .75 0.90 (0.84 – 0.97) 0.004
30% .70 0.92 (0.86 – 0.98) 0.009
40% .60 0.93 (0.88 – 0.99) 0.032
50% .50 0.94 (0.89 – 1.01) 0.073
!Uncertainty in the classification of smoking. The values represent hypothetical percentages of study participants potentially declining to reveal that they indeed
did smoke.
!!Sensitivity is defined as the probability of a true smoker being classified as a smoker.
!!!The one way sensitivity analysis evaluated the risk ratio under various sensitivity measures while holding the specificity fixed.
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was not statistically significant when the sensitivity was
set to be 0.50.
Running the probabilistic sensitivity analysis produced
a misclassification-bias-adjusted risk ratio of 0.34, 95%
CI 0.02 – 0.60.
Running simulations to account for possible uncer-
tainty in the classification of the SEIFA score resulted in
similar results as the study real data. No independent as-
sociations were observed between the disadvantage
SEIFA score and risk of TJR.
Discussion
In a large sample of elderly men and women, we have
found that smoking is independently and inversely asso-
ciated with undergoing a THR or TKR due to osteoarth-
ritis in both men and women. This inverse association
was observed after controlling for major confounders
and also after accounting for possible misclassification
biases.
A link between smoking and a protective mechanism
against osteoarthritis has been previously reported. Two
in-vitro studies have shown that this inverse relationship
may be associated with glycosaminoglycans (GAG) syn-
thesis [33], and with increased anabolic activity of the
chondrocytes in joint cartilage [34]. Nicotine was
reported to upregulate glycosaminoglycan and collagen
synthesis in a dose–response manner among smokers,
thus inhibiting the degeneration of joint structures [34].
Using magnetic resonance imaging, a third study found
a positive dose–response between pack-years of smoking
and tibial cartilage volume in healthy volunteers [35].
Our analysis is the largest cohort study to report inverse
associations between smoking and risk of either THR or
TKR due to osteoarthritis in both males and females.
This reduced risk persisted after adjusting for majorconfounders and also after accounting for possible mis-
classification in the smoking exposure variable. Our sen-
sitivity analyses showed that under a wide range of
uncertainty levels in the misclassification of smoking,
the significant inverse association between smoking and
TJR persisted. Only when the sensitivity of exposure to
smoking was as low as 0.50, the simulation produced a
non-significant result. A sensitivity of 0.50 would in-
crease the study’s observed number of smokers at base-
line from 3,535 to 24,075 smokers; a seven-fold increase
which seems very unlikely.
In a meta-analysis that assessed the association of
smoking with osteoarthritis, Hui et al. [19] evaluated 48
cross-sectional, case–control and cohort studies and
found an overall significant inverse association between
smoking and risk of OA (OR: 0.87, 95% CI 0.80-0.94).
Nonetheless, these authors concluded that such a nega-
tive association was most probably false resulting from a
possible selection bias of controls. The authors reported
that the negative association was predominantly demon-
strated in the case–control studies and suggested that
the results could have been biased by the inclusion of
controls from hospital settings where patients, in gen-
eral, were more likely to have higher exposure to smok-
ing than the general population. We agree that many of
the conditions for which patients are hospitalized may
be associated with smoking and the selection of controls
from such a population can bias results of case–control
studies of tobacco-related diseases as reported by
Morabia et al. [36]. However, unlike most of the studies
assessed by Hui et al., our study samples (both ANBP2
and our previous HIMS study) were community-based,
and such selection biases were unlikely. Moreover, out
of the 48 studies included in the Hui et al. meta-analysis,
40 (83%) were cross-sectional or case–control, and such
study designs are less appropriate to investigate any
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outcome [37]. In contrast, our study is longitudinal and
exposure to smoking preceded the event of interest.
Utilisation disparities of total joint replacement by
various socioeconomic groups have been reported
[16,18,38]. In addition to differences in co-morbidities
and level of education, those belonging to a low SES sta-
tus may be less willing to undergo this procedure com-
pared with the more affluent. Similarly, disparities in
undergoing a TJR procedure may be associated with
socio-economic access factors, and expectations about
the process and outcomes of the procedure [38,39]. Un-
like these reports, our longitudinal study did not find
significant differences in the utilisation rates of TJR by
various socio-economic groups. Our study population
was relatively old and, possibly, those coming from
lower socio-economic groups were under-represented.
This possible selective loss to follow-up may have
resulted in biased estimates of socio-economic inequal-
ities in the utilisation of TJR that may occur in a popula-
tion with a wider age range [40]. Similarly, the SEIFA
indices ranked socio-economic well-being of the popula-
tions within areas rather than individuals themselves.
Any area can include both relatively advantaged and dis-
advantaged people. Using the postcode may have intro-
duced some misclassifications; however, since the
postcode was provided by the participants, any misclas-
sifications were minimized which was also supported by
the probabilistic sensitivity analysis.
Strengths and limitations
This study has several strengths including its longitu-
dinal follow-up design, its large sample of participants of
both males and females, and the many years of past ex-
posure to smoking in our elderly participants. The link-
age of the participants' records to the national mortality
index data allowed us to account for all deaths in our
study population. Moreover, death which may be more
common among the elderly and especially among the
smokers was accounted for as a competing risk. To our
knowledge, this study is the first to assess risk of the
study outcome while accounting for uncertainty in the
exposure to smoking.
However, the study has limitations. Our retrospective
cohort study, which is the highest possible level of evi-
dence to investigate the relationship between smoking
and long-term outcomes, is not a randomised controlled
trial, thus confounding from other unaccounted factors
is always possible. Available data did not permit us to
control for duration or intensity of smoking, nor for past
history of traumatic injury or past stressful physical
work. Information on the physical activity of the partici-
pants was self-reported and not validated. The relatively
advanced age of the participants at baseline enabled usto account for the co-morbidities and also various mea-
sures of obesity present at baseline. Nonetheless, we
could not account for change in weight or co-
morbidities that may have occurred over the mean 8.6
(SD 3.4) years of follow-up. Notwithstanding, age, which
is often considered the simplest co-morbidity score [41],
was accounted for over the follow-up period. Our study
considered TJR as a surrogate indicator of severe osteo-
arthritis (OA). We therefore excluded all those who had
had a TJR procedure in the past. We could not exclude
those who had had hip or knee OA at baseline. The
complete national capture of all lower limb joint replace-
ments by the AOA NJRR was 2.3 (SD 0.6) years (mean)
after the recruitment of the ANBP2 participants. How-
ever, there is no evidence to indicate that the missed
procedures were more likely to be among smokers. We
used co-morbidities reported by the GPs, research
nurses and study participants to calculate the Charlson
Index. We had no access to medical charts and therefore
these co-morbidities were not validated. If co-morbidity
were underestimated, the risk of TJR among non-
smokers could have been overestimated (given that the
current smokers had more co-morbidities than the non-
smokers). Nonetheless, we constructed this co-morbidity
score (that is based on 17 co-morbid conditions includ-
ing various chronic pulmonary and other diseases) using
a similar approach as demonstrated by Chaudhry et al.
[30] who found high agreement levels between reported
co-morbid conditions and those recorded in administra-
tive datasets. Another explanation is the possibility of se-
lection biases prior to surgery. Heavy smokers may have
a lower chance of being put forward for surgery because
of medical concerns regarding worse outcomes in such
patients. However, a survey that sought to find indica-
tions for THR or TKR as perceived by orthopaedic sur-
geons showed that the decision against surgery was
mainly affected by patient age, co-morbidity, obesity, al-
cohol use, technical difficulties and lack of motivation
among the patients. Smoking was not indicated as a fac-
tor that would sway the decision against TKR or THR
[42]. Finally, the study population was relatively old and
our findings may not be generalizable to younger patient
populations.
Conclusion
The causal relationship of smoking with increased mor-
bidity and mortality from many illnesses is well
established; our results imply no support for the habit.
In our previous population-based study [9], we found an
independent inverse association between duration of
smoking and risk of undergoing a lower limb joint re-
placement in men, showing a dose–response relation-
ship. In this current longitudinal epidemiological study,
we wanted to validate our previous results on an
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sociations persisted after accounting for misclassification
biases. Using a large sample of 44,614 individuals, we
found that smoking was independently and inversely as-
sociated with having a total hip or knee replacements in
both men and women. This is the first epidemiological
study to show such consistent results in 1) males and
females, 2) older and relatively younger participants,
3) low, middle and high socioeconomic status groups,
4) obese and non-obese participants, 5) and in both total
knee and total hip replacements. Similarly, this is the
first study to demonstrate that the inverse association
between smoking and risk of TJR was more prominently
observed among the obese. The strengths of the inverse
association between smoking and TJR, the temporal
relationship of the association, together with the
consistency in the findings warrant further investigation
about the role of smoking in the pathogenesis of osteo-
arthritis leading to lower limb joint replacement.
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